Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 2, 2025
Hydreight Technologies Named One of the Americas’ Fastest Growing Companies by Financial Times
GlobeNewswire
·
April 2, 2025
VANCOUVER, British Columbia and LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth services in the U.S., has been named …
Prime Biome Reviews DON’T SKIP UNTIL SEE THIS for Preventing Fraud and Guaranteeing Reliability!
GlobeNewswire
·
April 2, 2025
ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- 2025, a popular supplement for reviving the gut and skin micro biota, Prime Biome has swept the wellness industry. Prime Biome is the greatest option for safe, healthy skin out of all the products …
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham …
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
GlobeNewswire
·
April 2, 2025
JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that the FDA has approved an Investigational Device Exemption (IDE) …
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
GlobeNewswire
·
April 2, 2025
HOUSTON, TX, April 02, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that it has successfully enrolled the …
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
GlobeNewswire
·
April 2, 2025
HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases …
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that …
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
GlobeNewswire
·
April 2, 2025
Event exploring the escalating threat of emerging infectious diseases Discussion covering going-private transaction with Aditxt, strategic growth partner HALIFAX, Nova Scotia, April 02, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: …
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
GlobeNewswire
·
April 2, 2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today reported …
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
GlobeNewswire
·
April 2, 2025
Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026 Alignment through recent interactions with CDER on path to accelerated approval and conversion to full approval …
Immunocore to present at upcoming investor conferences
GlobeNewswire
·
April 2, 2025
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England …
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
GlobeNewswire
·
April 2, 2025
Akoya’s technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer Equity Research, funded through the Cancer Grand Challenges initiative The unprecedented scale of the initiative requires the high plex and high throughput …
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that …
MUHC Foundation celebrates $200M Dream Big campaign milestone
GlobeNewswire
·
April 2, 2025
MONTREAL, April 02, 2025 (GLOBE NEWSWIRE) -- The McGill University Health Centre (MUHC) Foundation is proud to announce the successful completion of its ambitious Dream Big campaign, which has surpassed its $200 million fundraising goal. Launched in 2020 …
La campagne Oser rêver de la Fondation du CUSM franchit son objectif de 200 millions de dollars
GlobeNewswire
·
April 2, 2025
MONTRÉAL, 02 avr. 2025 (GLOBE NEWSWIRE) -- La Fondation du Centre universitaire de santé McGill (CUSM) est fière d’annoncer que son ambitieuse campagne Oser rêver a dépassé son objectif de financement de 200 millions de dollars. Lancée en 2020 durant une …
Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
THE WOODLANDS, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a presentation at the 24th Annual Needham Virtual Healthcare Conference 2025 on Wednesday, …
Opus Genetics to Participate in Upcoming Investor Conference in April
GlobeNewswire
·
April 2, 2025
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other …
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
GlobeNewswire
·
April 2, 2025
BVA and Pressure Session Attracted 400+ Clinicians; Duke University Showcased Valuable New BVA Findings in Dedicated Poster Presentation Oak Ridge, TN, April 02, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume …
Immutep to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 2, 2025
SYDNEY, AUSTRALIA , April 02, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces its management will present and …
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
GlobeNewswire
·
April 2, 2025
SAN CARLOS, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (“Allakos”) (Nasdaq: ALLK), a biotechnology company that has been developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today announced it has …